Lexaria Bioscience Corp (LEXX)

[corky2]

Chris Bunka responded to my email. It was a little difficult at first because the tone (my fault) of my initial email was a little over the top. We actually exchanged a couple of emails and smoothed things out. He's a quality guy. He's down 20 million on paper from the high. Of course he couldn't say too much. Like all shareholders he's disappointed it's taking so long to commercialize their tech and produce meaningful revenues. He assured me they're doing all they can to remedy that. He listed the companies accomplishments and on paper and they're impressive. He also made a good point about the Altria deal which we can all understand. They signed a deal with one of the one hundred largest companies in North America. Altria had more revenues last year than the entire legal North American cannabis industry put together. "Our tech was vetted by this industry giant and they have licensed our tech and agreed to pay us a royalty on any oral form of any nicotine product they make". As we know, the market gave them no valuation for this. If they had signed the exact same deal with Canopy, the market may have gotten all excited about it. He readily acknowledged they've been slow to the party, but I was left with the impression that these guys are busting their humps to make things happen. He did not address the ChargD+ delays and frankly I forgot to follow up on that. All in all I was left with a positive feeling and feel I have opened up a line of communication with him. Sorry nothing more tangible to give you.